Abstract
Background
The gastrointestinal tract (GIT) is subdivided into different anatomical organs with many shared functions and characteristics, but also distinct differences. We have combined a genome-wide transcriptomics analysis with immunohistochemistry-based protein profiling to describe the gene and protein expression patterns that define the human GIT.
Methods
RNA sequencing data derived from stomach, duodenum, jejunum/ileum and colon specimens were compared to gene expression levels in 23 other normal human tissues analysed with the same method. Protein profiling based on immunohistochemistry and tissue microarrays was used to sub-localize the corresponding proteins with GIT-specific expression into sub-cellular compartments and cell types.
Results
Approximately 75 % of all human protein-coding genes were expressed in at least one of the GIT tissues. Only 51 genes showed enriched expression in either one of the GIT tissues and an additional 83 genes were enriched in two or more GIT tissues. The list of GIT-enriched genes with validated protein expression patterns included various well-known but also previously uncharacterised or poorly studied genes. For instance, the colon-enriched expression of NXPE family member 1 (NXPE1) was established, while NLR family, pyrin domain-containing 6 (NLRP6) expression was primarily found in the human small intestine.
Conclusions
We have applied a genome-wide analysis based on transcriptomics and antibody-based protein profiling to identify genes that are expressed in a specific manner within the human GIT. These genes and proteins constitute important starting points for an improved understanding of the normal function and the different states of disease associated with the GIT.
Similar content being viewed by others
References
Mayer EA. Gut feelings: the emerging biology of gut-brain communication. Nat Rev Neurosci. 2011;12:453–66.
Holzer P, Reichmann F, Farzi A. Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis. Neuropeptides. 2012;46:261–74.
Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology. 2009;136:65–80.
O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006;7:688–93.
Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9:313–23.
Molodecky NA, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142:46–54 (e42 quiz e30).
Ferlay J, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
Dalerba P, et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol. 2011;29:1120–7.
Comelli EM, et al. Biomarkers of human gastrointestinal tract regions. Mamm Genome. 2009;20:516–27.
Fagerberg L, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014;13(2):397–406.
Ponten F, et al. The Human Protein Atlas as a proteomic resource for biomarker discovery. J Intern Med. 2011;270:428–46.
Kircher M, Sawyer S, Meyer M. Double indexing overcomes inaccuracies in multiplex sequencing on the Illumina platform. Nucleic Acids Res. 2012;40:e3.
Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas–a tool for pathology. J Pathol. 2008;216:387–93.
Kampf C, et al. Antibody-based tissue profiling as a tool in clinical proteomics. Clin Proteomics. 2004;1:285–300.
Trapnell C, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–5.
Hebenstreit D, et al. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol Syst Biol. 2011;7:497.
Kageyama T. Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. Cell Mol Life Sci. 2002;59:288–306.
van Driel IR, Callaghan JM. Proton and potassium transport by H+/K(+)-ATPases. Clin Exp Pharmacol Physiol. 1995;22:952–60.
Alpers DH, Russell-Jones G. Gastric intrinsic factor: the gastric and small intestinal stages of cobalamin absorption. a personal journey. Biochimie. 2013;95:989–94.
Ma K, Mallidis C, Bhasin S. The role of Y chromosome deletions in male infertility. Euro J Endocrinol. 2000;142:418–30.
Uhlen M, et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol. 2010;28:1248–50.
Fujimoto K, Polonsky KS. Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab. 2009;11(Suppl 4):30–7.
Guz Y, et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development. 1995;121:11–8.
Chen C, Sibley E. Expression profiling identifies novel gene targets and functions for Pdx1 in the duodenum of mature mice. Am J Physiol Gastrointest Liver Physiol. 2012;302:G407–19.
Holland AM, et al. The Parahox gene Pdx1 is required to maintain positional identity in the adult foregut. Int J Dev Biol. 2013;57:391–8.
Ose R, et al. PCDH24-induced contact inhibition involves downregulation of beta-catenin signaling. Mol Oncol. 2009;3:54–66.
Okazaki N, et al. Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis. 2002;23:1139–48.
Mashima H, et al. INSL5 may be a unique marker of colorectal endocrine cells and neuroendocrine tumors. Biochem Biophys Res Commun. 2013;432:586–92.
Thanasupawat T, et al. INSL5 is a novel marker for human enteroendocrine cells of the large intestine and neuroendocrine tumours. Oncol Rep. 2013;29:149–54.
Conklin D, et al. Identification of INSL5, a new member of the insulin superfamily. Genomics. 1999;60:50–6.
Liu C, et al. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem. 2005;280:292–300.
Pemberton AD, et al. Innate BALB/c enteric epithelial responses to Trichinella spiralis: inducible expression of a novel goblet cell lectin, intelectin-2, and its natural deletion in C57BL/10 mice. J Immunology. 2004;173:1894–901.
Wrackmeyer U, et al. Intelectin: a novel lipid raft-associated protein in the enterocyte brush border. Biochemistry. 2006;45:9188–97.
Elinav E, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745–57.
Hu B, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci. 2013;110:9862–7.
Sun Y, et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice. Gastroenterology. 2013;144(1478–87):e8.
Agius L. Glucokinase and molecular aspects of liver glycogen metabolism. Biochem J. 2008;414:1–18.
Gosmain Y, et al. Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in alpha-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes Metab. 2011;13(Suppl 1):31–8.
Bu H, et al. Anterior gradient 2 and 3–two prototype androgen-responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells. FEBS J. 2013;280:1249–66.
Diggle CP, et al. Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme. J Histochem Cytochem. 2009;57:763–74.
Shi H, et al. Overexpression of aminoacylase 1 is associated with colorectal cancer progression. Hum Pathol. 2013;44:1089–97.
Hsiao LL, et al. A compendium of gene expression in normal human tissues. Physiol Genomics. 2001;7:97–104.
Shyamsundar R, et al. A DNA microarray survey of gene expression in normal human tissues. Genome Biol. 2005;6:R22.
Lukk M, et al. A global map of human gene expression. Nat Biotechnol. 2010;28:322–4.
Hwang PI, et al. Tissue-specific gene expression templates for accurate molecular characterization of the normal physiological states of multiple human tissues with implication in development and cancer studies. BMC Genomics. 2011;12:439.
Magnusson K, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011;35:937–48.
Eberhard J, et al. A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer. 2012;106:931–8.
Ehlen A, et al. Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med. 2010;8:78.
Jonsson L, et al. Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study. J Transl Med. 2011;9:114.
Boman K, et al. Decreased expression of RBM3 correlates with tumour progression and poor prognosis in urinary bladder cancer. Histopathology. 2012;61:147.
Pacha J, Sumova A. Circadian regulation of epithelial functions in the intestine. Acta Physiol (Oxf). 2013;208:11–24.
Acknowledgments
Funding was provided by the Knut and Alice Wallenberg Foundation. Pathologists and staff at the Department of Clinical Pathology, Uppsala University Hospital are greatly acknowledged for providing the tissues used in the study, in particular, the authors would like to thank Simin Tahmasebpoor for excellent help with preparing frozen tissues for RNA extraction. The authors also wish to thank the staff of the Human Protein Atlas project in both Sweden and India for their efforts in generating the Human Protein Atlas.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
The study was approved by the Uppsala Ethical Review Board (Reference 2011/473).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gremel, G., Wanders, A., Cedernaes, J. et al. The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling. J Gastroenterol 50, 46–57 (2015). https://doi.org/10.1007/s00535-014-0958-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-014-0958-7